8-K filing — Glucotrack, Inc. (GCTK)
Filed: 2026-08-28 AccNo: 0001493152-26-040653 Size: 269 KB Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year Item 8.01: Other Events Item 9.01: Financial Statements and Exhibits
Stocks · News reference
Glucotrack Announces That Nasdaq Hearings Panel Has Granted The Company's Request For Continued Listing, Subject To Conditions
The Panel has confirmed that Glucotrack has regained compliance with Nasdaq's stockholders' equity requirement. The decision represents an important milestone in the Company's efforts to strengthen its
Reference Details
Connected Markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Checked
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related Headlines
8-K/A filing — Glucotrack, Inc. (GCTK)
Filed: 2026-08-28 AccNo: 0001493152-26-040600 Size: 1 MB Item 2.01: Completion of Acquisition or Disposition of Assets Item 9.01: Financial Statements and Exhibits
Glucotrack shares are trading lower after the company announced 1-for-15 reverse stock split, effective August 31.
Glucotrack Announces 1-For-15 Reverse Stock Split Effective August 31